FDA Covid-19 Response At a Glance Summary as of September 25, 2020

FDA Covid-19 Response At a Glance Summary as of September 25, 2020

Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

• The FDA issued an updated FDA COVID-19 Response At-A-Glance Summary which provides a quick look at facts, figures and highlights of the agency's response efforts.
• Testing updates:
  • As of today, 255 tests are authorized by FDA under EUAs; these include 204 molecular tests, 47 antibody tests, and 4 antigen tests.